header mobile logo


Ask your doctor which option is best for you.

How is Somatuline Depot administered?

Somatuline Depot (lanreotide) is an injection that should be given by a healthcare professional (or HCP) every 4 weeks. Nurse Home Health Administration (NHHA) may be available for patients who are unable to receive their Somatuline Depot injections at the doctor’s office:

  • Eligible patientsa can have a nurse visit their home or site of choice to administer their injections
  • There is no cost to the patient for this option

NHHA must be requested by the doctor and the patient must be enrolled in IPSEN CARES®.

aAdditional terms and conditions apply. Please visit for details.

As few as 7 doses a year for controlled patientsb,c

If your hormones and symptoms are controlledb,c, your doctor may offer to:

  • Continue giving you the same dose, or
  • Increase the dose to 120 mg and give you injections less often—every 6 or 8 weeks

b In patients whose acromegaly is controlled after 3 months of treatment. Controlled is defined as GH level from >1.0 ng/mL to ≤2.5 ng/mL, normalized IGF-1 level, and satisfactory management of clinical symptoms as determined by the healthcare provider. This dosing interval is based on controlled patients using 8-week dosing intervals after year 1.

c Patients who are controlled with Somatuline Depot 60 mg or 90 mg administered every 4 weeks can be considered for treatment with 120 mg administered every 6 or 8 weeks. GH and IGF-1 levels should be obtained 6 weeks after this change in dosing regimen to evaluate persistence of patient response. Continued monitoring of patients’ responses with dose adjustments for biochemical and clinical symptom control, as necessary, is recommended.


Patients receiving Somatuline® Depot administered once every 4 weeks


Patients receiving the Somatuline Depot 120-mg dose every 6 weeks


Patients receiving the Somatuline Depot 120-mg dose every 8 weeks

Redesigned in 2019 with you in mindd

Through a series of 4 studies between 2015 and 2017, Ipsen sought feedback from patients, nurses, and caregivers on the Somatuline Depot syringe. The syringe was then redesigned in 2019 based on this feedback.


Device not shown at actual size

Somatuline Depot is covered by most commercial insurance plans.

d Study Design: The Somatuline Depot delivery system was updated in 2019 to provide an improved ergonomic injection experience, based on user feedback. Through a series of 4 formative studies between 2015 and 2017, Ipsen sought feedback from patients, nurses, and caregivers on the design and functionality of updated delivery device prototypes. These culminated in a human factors validation study in 2017 in which the final delivery system prototype was tested to determine whether the product could be safely and effectively used by intended users in the intended use environment. Key changes between the previously marketed delivery system and the current delivery system are: an overcap to improve the ergonomics (and needle shield removal); plunger support for the current delivery system; and improved version of the needle safety system.


Do not take SOMATULINE DEPOT if you are allergic to lanreotide.

SOMATULINE DEPOT may cause serious side effects, including:

  • Gallstones
  • Changes to your blood sugar (high or low blood sugar),
  • Slow heart rate,
  • High blood pressure, and
  • Changes in thyroid function in acromegaly patients.

Tell your healthcare provider (HCP) if you have any of the following symptoms:

  • Symptoms of gallstones may include sudden pain in your upper right stomach area (abdomen), sudden pain in your right shoulder or between your shoulder blades, yellowing of your skin and whites of your eyes, fever with chills, and nausea.
  • Symptoms of high blood sugar may include increased thirst, increased appetite, nausea, weakness or tiredness, urinating more than normal, and fruity smelling breath.
  • Symptoms of low blood sugar may include dizziness or lightheadedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, irritability or mood changes, and hunger.
  • Symptoms of slow heart rate may include dizziness or lightheadedness, fainting or near-fainting, chest pain, shortness of breath, confusion or memory problems, and weakness or extreme tiredness.
  • SOMATULINE DEPOT can cause the thyroid gland to not make enough thyroid hormone in people with acromegaly. Symptoms of low thyroid levels may include fatigue, weight gain, puffy face, being cold all the time, constipation, dry skin, thinning or dry hair, decreased sweating, and depression.

The most common side effects of SOMATULINE DEPOT in people with acromegaly include diarrhea; stomach (abdominal) pain; nausea; and pain, itching, or a lump at the injection site.

SOMATULINE DEPOT may cause dizziness. If this happens, do not drive a car or operate machinery.

Tell your HCP right away if you have signs of an allergic reaction after receiving SOMATULINE DEPOT, including swelling of your face, lips or tongue; breathing problems; fainting, dizziness or feeling lightheaded (low blood pressure); itching; skin flushing or redness; rash; or hives.

Before taking SOMATULINE DEPOT, tell your HCP about all your medical conditions including if you: 
have diabetes; have gallbladder, heart, thyroid, kidney or liver problems; are pregnant or plan to become pregnant; or are breastfeeding or plan to breastfeed. It is not known if SOMATULINE DEPOT will harm your unborn baby or pass into breast milk. You should not breastfeed if you receive SOMATULINE DEPOT and for 6 months after your last dose. SOMATULINE DEPOT may affect your ability to become pregnant.

Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. SOMATULINE DEPOT and other medicines may affect each other, causing side effects. SOMATULINE DEPOT may affect the way other medicines work, and other medicines may affect how SOMATULINE DEPOT works. Your dose of SOMATULINE DEPOT or your other medications may need to be changed. If you have diabetes, your HCP may change your dose of diabetes medication when you first start receiving SOMATULINE DEPOT or if your dose of SOMATULINE DEPOT is changed.

Especially tell your HCP if you take:

  • Insulin or other diabetes medicines,
  • A cyclosporine (Gengraf, Neoral, or Sandimmune), or
  • Medicines that lower your heart rate, such as beta blockers.

Know the medicines you take. Keep a list of them to show your HCP when you get a new medicine.

Tell your HCP if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of SOMATULINE DEPOT. For more information, ask your HCP.

What is SOMATULINE® DEPOT (lanreotide) Injection?

SOMATULINE DEPOT is a prescription medicine used in adults for the long-term treatment of people with acromegaly when surgery or radiotherapy have not worked well enough or a patient is unable to have surgery or radiotherapy.

It is not known if SOMATULINE DEPOT is safe and effective in children.

To report SUSPECTED ADVERSE REACTIONS, contact Ipsen Biopharmaceuticals, Inc. at 1-855-463-5127 or FDA at 1-800-FDA-1088 or www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program.

Please click here for the full Prescribing Information and Patient Information.